EUVIMEDEUVIMED entdecken
Crossref

MANAGEMENT OF SUSPECTED DILATED CARDIOMYOPATHY WITH PIMOBENDAN IN TWO LEOPARD SHARKS (TRIAKIS SEMIFASCIATA)

Annabelle Vigneault, Natalie D Mylniczenko, Robert D Arnold, Shanese L Jasper-Trotter, Noémie Summa, Catherine Rousseau, Claire Vergneau-Grosset

Journal of Zoo and Wildlife Medicine · 07.07.2023 · 54 (2) · 401-405

DOI: 10.1638/2022-0084 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Zoo and Wildlife Medicine, erschienen am 07.07.2023. Verfasst von Annabelle Vigneault und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centre hospitalier universitaire vétérinaire affiliated with the Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, QC J2S 2M2…. Hauptthemen laut MEDLINE: Cardiomyopathy, Dilated, Pyridazines, Sharks. Die Arbeit nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Two adult male leopard sharks (Triakis semifasciata) under managed care were diagnosed with suspected dilated cardiomyopathy. Clinical signs included lethargy, inappetence, and regurgitation. On cardiac ultrasound, fractional shortening was 14% and 10%, respectively (versus 21%–31% in four healthy conspecifics). Ventricular end-diastolic diameter to body weight ratio was 1.72 cm/kg in Case 1 (versus 0.52–1.24 cm/kg in four conspecifics). These results collectively suggested a dilated cardiomyopathy. Treatment was implemented with oral pimobendan at 0.3 mg/kg q48h for 1 mon. The pimobendan dose was increased to 0.5 mg/kg 3/wk, following plasmatic dosage of pimobendan and its metabolite. After 3 mon, fractional shortening increased to 38% and 20%, respectively, sharks regained a normal appetite, and body weight increased by 50% in one individual. After 2 yr, both individuals remained clinically normal, and no adverse effect was noted with pimobendan administration. Pimobendan plasma concentration suggested that this medication was well absorbed in this species.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiomyopathy, DilatedPyridazinesSharksMaleAnimalsBody WeightCardiotonic Agents

Substanzen

pimobendanPyridazinesCardiotonic Agents

Autor:innen und Institutionen

  • Centre hospitalier universitaire vétérinaire affiliated with the Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, QC J2S 2M2, Canada.
  • Disney's Animals, Science and Environment, Walt Disney World, Lake Buena Vista, FL 32830, USA.
  • Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, AL 36849, USA.
  • Aquarium du Québec, Québec, QC G1W 4S3, Canada.
  • Département de sciences cliniques, Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, QC J2S 2M2, Canada, claire.grosset@umontreal.ca.

Zitieren

APA

Vigneault, A., Mylniczenko, N. D., Arnold, R. D., Jasper-Trotter, S. L., Summa, N., Rousseau, C., & Vergneau-Grosset, C. (2023). MANAGEMENT OF SUSPECTED DILATED CARDIOMYOPATHY WITH PIMOBENDAN IN TWO LEOPARD SHARKS (TRIAKIS SEMIFASCIATA). Journal of Zoo and Wildlife Medicine, 54(2), 401-405. https://doi.org/10.1638/2022-0084

Vancouver

Vigneault A, Mylniczenko ND, Arnold RD, Jasper-Trotter SL, Summa N, Rousseau C, et al. MANAGEMENT OF SUSPECTED DILATED CARDIOMYOPATHY WITH PIMOBENDAN IN TWO LEOPARD SHARKS (TRIAKIS SEMIFASCIATA). Journal of Zoo and Wildlife Medicine. 2023;54(2):401-405. doi:10.1638/2022-0084

BibTeX
@article{Vigneault2023,
  author = {Vigneault, Annabelle and Mylniczenko, Natalie D and Arnold, Robert D and Jasper-Trotter, Shanese L and Summa, Noémie and Rousseau, Catherine and Vergneau-Grosset, Claire},
  title = {MANAGEMENT OF SUSPECTED DILATED CARDIOMYOPATHY WITH PIMOBENDAN IN TWO LEOPARD SHARKS (TRIAKIS SEMIFASCIATA)},
  journal = {Journal of Zoo and Wildlife Medicine},
  year = {2023},
  volume = {54},
  number = {2},
  pages = {401--405},
  doi = {10.1638/2022-0084}
}
Kostenlos starten →